Pharmaceutical Executive Europe - January 2008 - (Page 3)

Pharmaceutical Executive Europe January 2008 Contents 3 Pharmaceutical Executive Advancing business leadership www.pharmexeceurope.com Corporate Strategy Walking the Line Brian D. Smith There is more to innovation than invention and insight. And how do good firms make it pay? page 14 Executive Profile The Pharmacist’s Friend Pharm Exec Europe Gary Noon, Aegate CEO, talks about the new role of the pharmacist in the future of patient safety. page 18 Q&A An End to Drug Counterfeiting Ton van Lierop Interview with an official from the cabinet of EC vice president Günter Verheugen. page 20 Healthcare Cost Assessment Ready to Make NICE? François Lucas Perspectives on the growing number of countries implementing cost-effectiveness evaluations. page 22 Pricing and Reimbursement Generics Through the Reimbursement Barriers India Inc. Brian Lovatt How can cancer drug development companies clear the pricing and reimbursement hurdles? page 25 Urmila Doraswami and Edwin Bailey How Indian companies are fully exploiting the significant growth of the generics market. page 28 Regulars From the Editor A NICE change News and Analysis Calendar 4 6 12 The Mix New Models of Excellence S. Danner, A. Ruzicic and M. Oelschlegel In these turbulent times, commercial excellence is the best way for pharma companies to survive. page 31 Last Word Mid-size Matters Luciano Conde Are mid-size pharma companies best positioned to succeed in today’s market? page 35 http://www.pharmexeceurope.com

Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe - January 2008

Pharmaceutical Executive Europe - January 2008 Contents From the Editor News and Analysis Calendar Corporate Strategy: Walking the Line Executive Profile: The Pharmacist’s Friend Q&A: An End to Drug Counterfeiting Healthcare Cost Assessment: Ready to Make NICE? Pricing and Reimbursement: Through the Reimbursement Barriers Generics: India Inc. The Mix: New Models of Excellence Last Word: Mid-size Matters

Pharmaceutical Executive Europe - January 2008

Pharmaceutical Executive Europe - January 2008 - Pharmaceutical Executive Europe - January 2008 (Page 1) Pharmaceutical Executive Europe - January 2008 - Pharmaceutical Executive Europe - January 2008 (Page 2) Pharmaceutical Executive Europe - January 2008 - Contents (Page 3) Pharmaceutical Executive Europe - January 2008 - From the Editor (Page 4) Pharmaceutical Executive Europe - January 2008 - From the Editor (Page 5) Pharmaceutical Executive Europe - January 2008 - News and Analysis (Page 6) Pharmaceutical Executive Europe - January 2008 - News and Analysis (Page 7) Pharmaceutical Executive Europe - January 2008 - News and Analysis (Page 8) Pharmaceutical Executive Europe - January 2008 - News and Analysis (Page 9) Pharmaceutical Executive Europe - January 2008 - News and Analysis (Page 10) Pharmaceutical Executive Europe - January 2008 - News and Analysis (Page 11) Pharmaceutical Executive Europe - January 2008 - Calendar (Page 12) Pharmaceutical Executive Europe - January 2008 - Calendar (Page 13) Pharmaceutical Executive Europe - January 2008 - Corporate Strategy: Walking the Line (Page 14) Pharmaceutical Executive Europe - January 2008 - Corporate Strategy: Walking the Line (Page 15) Pharmaceutical Executive Europe - January 2008 - Corporate Strategy: Walking the Line (Page 16) Pharmaceutical Executive Europe - January 2008 - Corporate Strategy: Walking the Line (Page 17) Pharmaceutical Executive Europe - January 2008 - Executive Profile: The Pharmacist’s Friend (Page 18) Pharmaceutical Executive Europe - January 2008 - Executive Profile: The Pharmacist’s Friend (Page 19) Pharmaceutical Executive Europe - January 2008 - Q&A: An End to Drug Counterfeiting (Page 20) Pharmaceutical Executive Europe - January 2008 - Q&A: An End to Drug Counterfeiting (Page 21) Pharmaceutical Executive Europe - January 2008 - Healthcare Cost Assessment: Ready to Make NICE? (Page 22) Pharmaceutical Executive Europe - January 2008 - Healthcare Cost Assessment: Ready to Make NICE? (Page 23) Pharmaceutical Executive Europe - January 2008 - Healthcare Cost Assessment: Ready to Make NICE? (Page 24) Pharmaceutical Executive Europe - January 2008 - Pricing and Reimbursement: Through the Reimbursement Barriers (Page 25) Pharmaceutical Executive Europe - January 2008 - Pricing and Reimbursement: Through the Reimbursement Barriers (Page 26) Pharmaceutical Executive Europe - January 2008 - Pricing and Reimbursement: Through the Reimbursement Barriers (Page 27) Pharmaceutical Executive Europe - January 2008 - Generics: India Inc. (Page 28) Pharmaceutical Executive Europe - January 2008 - Generics: India Inc. (Page 29) Pharmaceutical Executive Europe - January 2008 - Generics: India Inc. (Page 30) Pharmaceutical Executive Europe - January 2008 - The Mix: New Models of Excellence (Page 31) Pharmaceutical Executive Europe - January 2008 - The Mix: New Models of Excellence (Page 32) Pharmaceutical Executive Europe - January 2008 - The Mix: New Models of Excellence (Page 33) Pharmaceutical Executive Europe - January 2008 - The Mix: New Models of Excellence (Page 34) Pharmaceutical Executive Europe - January 2008 - Last Word: Mid-size Matters (Page 35) http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091222http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091208http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091124http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091110http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091027http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091013http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_DIGEST_20090930http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_digest_20090916http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090902http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090825http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090819http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090812http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090805http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090729http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090721http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090715http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090708http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090701http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090624http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090617http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090610http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090602http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090526http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090519http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090512http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090505http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_southafricahttp://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090429http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090422http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090415http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090408http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401_v2http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090325http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090318http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090311http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090304http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090224http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090218http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090211http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090203http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090128http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090121http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090114http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1008http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1008http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0908http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0808http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0708http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0608http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0508http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0508http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0408http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0308http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0208http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0208http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0108http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1207http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1107http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1007http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imsoncology0907http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0407http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0307http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1206http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.